1
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Significance of adrenoceptor-mediated atrial natriuretic factor release in normal humans

Pages 73-84 | Received 02 Apr 1990, Accepted 17 Sep 1990, Published online: 26 Feb 2018

REFERENCES

  • de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981; 28: 89–94.
  • de Lean A, Racz K, Gutkowska J, Nguyen T-T, Cantin M, Genest J. Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology 1984; 115: 1636–8.
  • Atlas SA, Volpe M, Sosa RE, Laragh JH, Camargo MJF, Maack T. Effects of atrial natriuretic factor on blood pressure and the reninangiotensin-aldosterone system. Fed Proc 1986; 45: 2115–21.
  • Kangawa K, Matsuo H. Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP). Biochem Biophys Res Commuti 1984; 118: 131–9.
  • Schwartz D, Geller DM, Manning PT, Siegel NR, Fok KF, Smith CE, Needleman P. Ser-Leu-Arg-Atriopeptin III: the major circulating form of atrial peptide. Science 1985; 229: 397–400.
  • Larose P, Meloche S, du Souich P, deLean A, Ong H. Radioimmunoassay of atrial natriuretic factor: human plasma levels. Biochem Biophys Res Commun 1985; 130: 553–8.
  • Ledsome JR, Wilson N, Courneya CA, Rankin AJ. Release of atrial natriuretic peptide by atrial distension. Can J Physiol Pharmacol 1985; 63: 739–42.
  • Katsube N, Schwartz D, Neeleman P. Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure. Biochem Biophys Res Commun 1985; 133: 937–44.
  • Akabane S, Kojima S, Igarashi Y, Kawamura M, Matsushima Y, Ito K. Release of atrial natriuretic polypeptide by graded right atrial distension in anesthetized dogs. Life Sci 1987; 40: 119–25.
  • Dietz JR. Control of atrial factor release from a rat heart-lung preparation. Am J Physiol 1987; 252: R498–502
  • Pendergast DR, de Bold AJ, Pazik M, Hong SK. Effect of head-out immersion on plasma atrial natriuretic factor in man. Proc Soc Exp Biol Med 1987; 184: 429–35.
  • Müller FB, Erne P, Raine AEG, Bolli P, Linder L, Resink TJ, Cottier C, Bühler FR. Atrial antipressor natriuretic peptide: release mechanisms and vascular actions in man. J Hypertens 1986; 4 (Suppl. II): 109–14.
  • Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor—a circulating hormone stimulated by volume loading. Nature 1985; 314: 264–6.
  • Verburg KM, Freeman RH, Davis JO, Villarreal D, Vari RC. Control of atrial natriuretic factor realease in conscious dogs. Am J Physiol 1986; 251: R947–R956
  • Andersson OK, Persson B, Wysocki M, Berglund G, Towle AC, Aurell M, Hedner J, Hedner T. Significant relationship between renin suppression and atrial natriuretic peptide (hANP) during volume loading in hypertensive man. Acta Med Scand 1987; 221: 137–42.
  • Sagnella GA, Markandu ND, Shore C, MacGregor GA. Plasma immunoreactive atrial natriuretic peptide and changes in dietary sodium intake in man. Life Sci 1986; 40: 139–43.
  • Solomon LR, Atherton JC, Bobinski H, Green R. Effect of dietary sodium chloride and posture on plasma immunoreactive atrial natriuretic peptide concentrations in man. Clin Sci 1987; 72: 201–8.
  • Anderson JV, Gibbs JSR, Woodruff PWR, Greco C, Rowland E, Bloom SR. The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. J Hypertens 1986; 4 (Suppl. II): 137–41.
  • Roy D, Paillard F, Cassidy D, Bourassa MG, Gutkowska J, Genest J, Cantin M. Atrial natriuretic factor during atrial fibrillation and supraventricular tachycardia. J Am Coll Cardiol 1987; 9: 509–14.
  • Sonnenberg H, Veress AT. Cellular mechanism of release of atrial natriuretic factor. Biochem Biophys Res Commun 1984; 124: 443–9.
  • Garcia R, Lahance D, Thibault G, Cantin M, Gutkowska J. Mechanisms of release of atrial natriuretic factor. II. Effect of chronic administration of α-and β-adrenergic and cholinergic agonists on plasma and atrial ANF in the rat. Biochem Biophys Res Commun 1986; 136: 510–20.
  • Baranowska B, Gutkowska J, Cantin M, Genest J. Plasma immunoreactive atrial natriuretic factor (IR-ANF) increases markedly after αl2-adrenergic stimulation with Clonidine in normally hydrated rats. Biochem Biophys Res Commun 1987; 143: 159–63.
  • Baranowska B, Gutkowska J, Cantin M, Genest J. Effects of α1,- and α2-adrenergic agonists on plasma immunoreactive atrial natriuretic factor (IR-ANF) in conscious rats. Neuroendocrinol Lett 1987; 4: 261–6.
  • Baranowska B, Gutkowska J, Talbot P, Genest J, Cantin M. Plasma immunoreactive atrial natriuretic factor is inhibited by selective blockade of α2- adrenergic receptors in conscious Sprague-Dawlcy rats. Neurosci Lett 1987; 76: 119–23.
  • Sanfield JA, Shenker Y, Grekin RJ, Rosen SG. Epinephrine increases plasma immunoreactive atrial natriuretic hormone levels in humans. Am J Physiol 1987; 252: E740–5.
  • Uehlinger DE, Weidmann P, Gnaedinger MP, Shaw S, Lang RE. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrinol Metab 1986; 63: 669–74.
  • Storm TL, Thamsborg G, Sykulski R, Keller N, Thomsen J, Larsen J. Radio-immunoassay of atrial natriuretic peptide in human plasma. Scand J Clin Lab Invest 1987; 47: 745–8.
  • Eriksson BM, Persson BA. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 1982; 228: 143–54.
  • Wong NML, Wong EFC, Au GH, Hu DCK. Effect of α- and β-adrenergic stimulation on atrial natriuretic peptide release in vitro. Am J Physiol 1988; 255: E260–4.
  • Schiebinger RJ, Baker MZ, Linden J. Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. J Clin Invest 1987; 80: 1687–91.
  • Ruskoaho H, Leppäluoto J. The effect of medeto- midine, an α2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats. Br J Pharmacol 1989; 97: 125–32.
  • Uehlinger DE, Zaman T, Weidmann P, Shaw S, Gnädinger MP. Pressure dependence of atrial natriuretic peptide during norepinephrine infusion in humans. Hypertension 1987; 10: 249–53.
  • Thamsborg G, Sykulski R, Larsen J, Storm T, Keller N. Effect of β1-adrenoceptor blockade on plasma levels of atrial natriuretic peptide during exercise in normal man. Clin Physiol 1987; 7: 313–8.
  • Keller N. Atrial natriuretic factor and central venous pressure during intermittent and continuous lower-body positive pressure in healthy humans. Clin Physiol 1990; 10: 245–55.
  • Obata K, Yasue H, Okumura K, Matsuyama K, Ogawa H, Kurose M, Nakao K, Imura H. Increased secretion of atrial natriuretic polypeptide in response to cardiac pacing. JPN Circ J 1989; 53: 1055–60.
  • Keller N, Sykulski R, Larsen J. Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure. Clin Physiol 1991; (in press).
  • Nguyen PV, Smith DL, Leenen FHH. Acute volume loading, atrial natriuretic peptide release and cardiac function in healthy men. Effects of β- blockade. Life Sci 1988; 43: 821–30.
  • Onwochei MO, Rapp JP. Biochemically stimulated release of atrial natriuretic factor from heart-lung preparation of Dahl rats. Proc Soc Exp Biol Med 1988; 188: 395–404.
  • Kallio A, Scheinin M, Koulu M, Ponkilainen R, Ruskoaho H, Viinamaki O, Scheinin H. Effects of dexmedetomidine, a selective alpha-2-adrenoccptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther 1989; 46: 33–42.
  • Sato F, Kamoi K, Wakiya Y, Ozawa T, Arai O, Ishibashi M, Yamaji T. Relationship between plasma atrial natriuretic peptide levels and atrial pressure in man. J Clin Endocrinol Metab 1986; 63: 823–7.
  • Asai J, Nakazato M, Toshimori H, Matsukura S, Kangawa K, Matsuo H. Presence of atrial natriuretic polypeptide in the pulmonary vein and vena cava. Biochem Biophys Res Commun 1987; 146: 1465–70.
  • Larsen TH. Immunocytochemical localization of atrial natriuretic peptide in the venae cavae and the pulmonary veins of the rat. Histochem J 1988; 20: 69–74.
  • MeLeod AA, Brown JE, Kitchell BB, Sedor FA, Kuhn C, Shand DG, Williams RS. Hemodynamic and metabolic responses to exercise after adrenoceptor blockade in humans. J Appl Physiol 1984; 56: 716–22.
  • Itskovitz HD. Clonidine and the kidney. J Cardiovasc Pharmacol 1980; 2 (Suppl. 1): S47–S60.
  • Saeed M, Sommer O, Holtz J, Bassenge E. α- adrenoceptor blockade by phentolamine causes β- adrenergic vasodilation by increased catecholamine release due to presynaptic α-blockade. J Cardiovasc Pharmacol 1982; 4: 44–52.
  • Trovati M, Massucco P, Mularoni E, Cavalot F, Anfossi G, Mattiello L, EmanueUi G. Insulin-induced hypoglycaemia increases plasma concentrations of angiotensin II and does not modify atrial natriuretic polypeptide secretion in man. Diabetologia 1988; 31: 816–20.
  • Volpe M, DeLuca N, Atlas SA, Camargo MJ, Indolfi C, Lembo G, Trimarco B, Condorelli M, Laragh JH. Reduction of atrial natriuretic factor levels by endogenous sympathetic activation in hypertensive patients. Circulation 1988; 77: 997–1002.
  • Houston MC. The comparative effects of clonidine hydrochloride and nifedipine in the treatment of hypertensive crises. Am Heart J 1988; 115: 152–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.